1. Home
  2. ADVB vs WVVI Comparison

ADVB vs WVVI Comparison

Compare ADVB & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVB
  • WVVI
  • Stock Information
  • Founded
  • ADVB 2014
  • WVVI 1983
  • Country
  • ADVB United States
  • WVVI United States
  • Employees
  • ADVB N/A
  • WVVI N/A
  • Industry
  • ADVB Medical Specialities
  • WVVI Beverages (Production/Distribution)
  • Sector
  • ADVB Health Care
  • WVVI Consumer Staples
  • Exchange
  • ADVB Nasdaq
  • WVVI Nasdaq
  • Market Cap
  • ADVB 36.1M
  • WVVI 31.0M
  • IPO Year
  • ADVB 2025
  • WVVI N/A
  • Fundamental
  • Price
  • ADVB $0.95
  • WVVI $5.80
  • Analyst Decision
  • ADVB
  • WVVI
  • Analyst Count
  • ADVB 0
  • WVVI 0
  • Target Price
  • ADVB N/A
  • WVVI N/A
  • AVG Volume (30 Days)
  • ADVB 182.8K
  • WVVI 4.9K
  • Earning Date
  • ADVB 01-01-0001
  • WVVI 05-20-2025
  • Dividend Yield
  • ADVB N/A
  • WVVI N/A
  • EPS Growth
  • ADVB N/A
  • WVVI N/A
  • EPS
  • ADVB N/A
  • WVVI N/A
  • Revenue
  • ADVB N/A
  • WVVI $39,782,442.00
  • Revenue This Year
  • ADVB N/A
  • WVVI N/A
  • Revenue Next Year
  • ADVB N/A
  • WVVI N/A
  • P/E Ratio
  • ADVB N/A
  • WVVI N/A
  • Revenue Growth
  • ADVB N/A
  • WVVI 1.65
  • 52 Week Low
  • ADVB $1.01
  • WVVI $3.17
  • 52 Week High
  • ADVB $4.10
  • WVVI $6.33
  • Technical
  • Relative Strength Index (RSI)
  • ADVB N/A
  • WVVI 41.75
  • Support Level
  • ADVB N/A
  • WVVI $5.42
  • Resistance Level
  • ADVB N/A
  • WVVI $6.07
  • Average True Range (ATR)
  • ADVB 0.00
  • WVVI 0.12
  • MACD
  • ADVB 0.00
  • WVVI -0.04
  • Stochastic Oscillator
  • ADVB 0.00
  • WVVI 50.67

About ADVB Advanced Biomed Inc. Common Stock

Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: